Freenome

Company Deals

Freenome Roche Cancer Screening Deal Worth Over $200M

Fineline Cube Nov 20, 2025

Freenome, a California‑based early cancer detection company, announced a strategic collaboration with Roche (SWX: ROG,...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod